Related Experiment Video
Updated: Mar 13, 2026

Double Direct Injection of Blood into the Cisterna Magna as a Model of Subarachnoid Hemorrhage
Published on: August 30, 2020
Stable incidence but declining case-fatality rates of subarachnoid hemorrhage in a population
Jason Mackey1, Jane C Khoury2, Kathleen Alwell2
1From the Department of Neurology (J.M.), Indiana University School of Medicine, Indianapolis; Division of Biostatistics and Epidemiology (J.C.K.), Cincinnati Children's Hospital; Departments of Neurology (K.A., C.J.M., B.M.K., M.L.F., D.W., S.F., F.D.L.R.L.R., P.K., J.P.B., D.K.), Emergency Medicine (O.A.), and Neurosurgery (M.Z.), University of Cincinnati College of Medicine, OH; Department of Neurology (F.D.L.R.L.R.), University of New Mexico Health Sciences Center, Albuquerque; and Department of Neurology (S.M.), Baylor College of Medicine, Houston, TX. jsmackey@iupui.edu.
Objective:
To characterize temporal trends in subarachnoid hemorrhage (SAH) incidence and outcomes over 5 time periods in a large population-based stroke study in the United States.
Methods:
All SAHs among residents of the Greater Cincinnati/Northern Kentucky region at least 20 years of age were identified and verified via study physician review in 5 distinct year-long study periods between 1988 and 2010. We abstracted demographics, care patterns, and outcomes, and we compared incidence and case-fatality rates across the study periods.
Results:
The incidence of SAH in the 5 study periods (age-, race-, and sex-adjusted to the 2000 US population) was 8.8 (95% confidence interval 6.8-10.7), 9.2 (7.2-11.2), 10.0 (8.0-12.0), 9.0 (7.1-10.9), and 7.7 (6.0-9.4) per 100,000, respectively; the trend in incidence rates from 1988 to 2010 was not statistically significant (p = 0.22). Advanced neurovascular imaging, endovascular coiling, and neurologic intensive care unit availability increased significantly over time. All-cause 5-day (32%-18%, p = 0.01; for trend), 30-day (46%-25%, p = 0.001), and 90-day (49%-29%, p = 0.001) case-fatality rates declined from 1988 to 2010. When we included only proven or highly likely aneurysmal SAH, the declines in case-fatality were no longer statistically significant.
Conclusions:
Although the incidence of SAH remained stable in this population-based region, 5-day, 30-day, and 90-day case-fatality rates declined significantly. Advances in surgical and medical management, along with systems-based changes such as the emergence of neurocritical care units, are potential explanations for the reduced case-fatality.
More Related Videos
Related Concept Videos
Hazard Rate
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Actuarial Approach
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...

